{
  "trial_id": "NCT06074497",
  "title": "This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.",
  "condition": "Advanced or Metastatic Solid Tumors",
  "participant_count": 54,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 48.148148148148145,
    "std": 15.54956458458213,
    "min": 20,
    "max": 80
  },
  "gender_distribution": {
    "male": 0.5274560249914587,
    "female": 0.4725439750085413
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 54,
  "eligibility_score": 0.8202443205200868
}